Across TCGA pan-cancer cohorts, RPS15AP9 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of RPS15AP9’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where RPS15AP9 RNA is repressed in tumor relative to normal tissue. In most cancer types RPS15AP9 is over-expressed in tumor, although a few such as BRCA and KIRC show the opposite, repressed pattern.

BRCA, LUAD, and KIRC are the cancer types where RPS15AP9 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPS15AP9 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	All	III,IV	−0.258	.022	2	view →
LUAD	All	All	+0.081	.003	2	view →
KIRC	All	IV	−0.041	.022	2	view →
CHOL	All	All	+0.316	.013	1	view →
LUSC	All	All	+0.065	.007	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

Exploration

Same gene, other analysis: RPS15AP9 RNA expression & survival · all RPS15AP9 data types